Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Neurology | Psychiatry/Psychology | Pediatrics/Neonatology
Disease Category: Attention Deficit/Hyperactivity Disorder (ADHD - Pediatric)
Trial Information
A Phase III Evaluation of the Efficacy and Safety of XXXX as Add-on to Psychostimultant Medication Alone in the Treatment of Children and Adolescents with Attention Deficit Hyperactivity Disorder (ADHD)
Patient Inclusion Criteria:
- Between the ages of 6 – 17
- Diagnosed with ADHD
- Ability to swallow tablets
Patient Exclusion Criteria:
- History of seizures, except for a single episode of febrile seizure prior to age 2
- Use of any investigational drug with in 30 days of study start
- Female of child bearing potentials, pregnant or lactating
Lisa Wilkins
CRI Worldwide
130 White Horse Pike
Clementon, NJ 08021
Phone: 877-993-2583 ext, 213
Fax: 856-566-9701
EMail: lwilkins@criww.com
View Google Map
Research Center Information: CRI Worldwide
If you would like to learn more about participating in this study, please send an e-mail message using the form below.
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these
trials.
